Published on
March 12, 2026
- 20:04 GMT
Hawkeye Bio Granted U.S. Patent for Graphene Biosensor Platform Enabling Ultra-Sensitive Protease Biomarker Detection
Patent covers pristine graphene–based biosensor technology to translate protease activity into measurable optical signals for early cancer detection WESTLAKE VILLAGE, CA, UNITED STATES, March 12, 2026 /EINPresswire.com/ -- Hawkeye Bio, Inc. announced …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
